ADVANCE ONLINE PUBLICATION
The latest research papers, published online ahead of print. These online versions are definitive and may be cited using the digital object identifier (DOI).
About advance online publication
November 3 2009 |
October 27 2009 |
September 22 2009 |
August 11 2009 |
May 26 2009 |
April 21 2009 |
April 7 2009 |
March 17 2009
November 10 2009
Original Articles
The current M&A environment and its strategic implications for emerging biotherapeutics companies
Mohan Sowlay and Scott Lloyd
J Commer Biotechnol advance online publication, November 10, 2009; doi:10.1057/jcb.2009.35
Biotechnology in the capital region of Europe
Jan Wauters
J Commer Biotechnol advance online publication, November 10, 2009; doi:10.1057/jcb.2009.34
November 3 2009
Original Article
Practical approaches to early stage life sciences technology valuations
Stephen Mayhew
J Commer Biotechnol advance online publication, November 3, 2009; doi:10.1057/jcb.2009.31
October 27 2009
Original Articles
From carbon to carbohydrates: Corporate strategies for biopolymer technology development
Avrath Chadha
J Commer Biotechnol advance online publication, October 27, 2009; doi:10.1057/jcb.2009.30
Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime
Trichi Saukshmya and Archana Chugh
J Commer Biotechnol advance online publication, October 27, 2009; doi:10.1057/jcb.2009.28
September 22 2009
Commentary
Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski and Elizabeth A Jex
J Commer Biotechnol advance online publication, September 22, 2009; doi:10.1057/jcb.2009.27
August 11 2009
Original Article
Ethiopia: Biotechnology for development
Desta Berhe Sbhatu
J Commer Biotechnol advance online publication, August 11, 2009; doi:10.1057/jcb.2009.21
May 26 2009
Original Articles
Biotechnology marketing: Insider and outsider views
Päivi Eriksson and Heidi Rajamäki
J Commer Biotechnol advance online publication, May 26, 2009; doi:10.1057/jcb.2009.16
Challenges and opportunities in the licensing of renewable technologies
Meredith Lloyd-Evans, Mike Gilbert and Ilian P Iliev
J Commer Biotechnol advance online publication, May 26, 2009; doi:10.1057/jcb.2009.10
April 21 2009
Original Article
Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes
J Commer Biotechnol advance online publication, April 21, 2009; doi:10.1057/jcb.2009.13
April 7 2009
Original Article
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms
Mark J Ahn, Michael Meeks, Sally Davenport and Rebecca Bednarek
J Commer Biotechnol advance online publication, April 7, 2009; doi:10.1057/jcb.2009.8
